California State Teachers Retirement System (CalSTRS)’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53K Sell
1,431
-4,142
-74% -$12.1K ﹤0.01% 2944
2026
Q1
$20.9K Buy
5,573
+265
+5% +$1.04K ﹤0.01% 2424
2025
Q4
$18.7K Sell
5,308
-689
-11% -$2.8K ﹤0.01% 2542
2025
Q3
$24K Buy
5,997
+3
+0.1% +$9 ﹤0.01% 2487
2025
Q2
$16.1K Hold
5,994
– – ﹤0.01% 2561
2025
Q1
$8.45K Hold
5,994
– – ﹤0.01% 2815
2024
Q4
$11.9K Hold
5,994
– – ﹤0.01% 2797
2024
Q3
$18.9K Buy
5,994
+921
+18% +$2.9K ﹤0.01% 2633
2024
Q2
$16K Buy
+5,073
New +$20.2K ﹤0.01% 2682

Other funds holding ADCT

California State Teachers Retirement System (CalSTRS)'s ADCT Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its ADC Therapeutics (ADCT) stake by 74% in Q2 2026, selling an estimated $12.1K and leaving 1,431 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2944.

California State Teachers Retirement System (CalSTRS) first reported a position in ADCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $24K in Q3 2025. 113 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 1,431 shares of ADC Therapeutics worth $1.53K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 4,142 ADC Therapeutics shares in Q2 2026, an estimated $12.1K.
  • ADC Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2944 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in ADC Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s ADC Therapeutics position peaked at $24K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.